Symbiotic AI Awarded Prestigious Enabling Better Health through Artificial Intelligence (AI-Better Health) Program Funding to Advance Heart Healthcare Innovation

Author

/

Symbiotic AI

Date

/

May 30, 2024

S

ymbiotic AI, a Calgary based leading developer of clinical decision support software, is proud to announce that it has been granted significant funding under the Enabling Better Health through Artificial Intelligence (AI-Better Health) Program to further its mission of improving heart healthcare and patient outcomes. This competitive funding, awarded by Alberta Innovates, underscores the innovative potential and impact of Symbiotic AI's technology in the healthcare sector.

quotations icon
This funding will enable us to advance the development of our technology and extend its reach, which will significantly bolster our efforts to transform heart healthcare.quotations icon

Arjun Puri, CEO and cofounder of Symbiotic AI

image placeholder

The AI-Better Health Program aims to position Alberta as a leader in data-driven and data-enabled innovation through the application of artificial intelligence to enhance health outcomes. The program provides project funding to address critical issues in data quality, access, privacy, and the ethical, regulatory, and societal implications of AI in healthcare.

Words from Symbiotic AI

"We are honored to receive this prestigious project funding, which will significantly bolster our efforts to transform heart healthcare," said Arjun Puri, CEO and cofounder of Symbiotic AI. "This funding will enable us to advance the development of our technology and extend its reach, ultimately leading to better patient outcomes and more efficient healthcare delivery."

Symbiotic AI's software leverages advanced artificial intelligence and machine learning algorithms to analyze patient data and provide actionable insights to clinicians treating patients with coronary artery disease. By integrating seamlessly with existing healthcare systems, Symbiotic AI's tools enhance treatment planning, reduce the risk of adverse events, and save valuable physician time. Symbiotic AI's project aligns with the AI-Better Health Program's objectives by developing solutions that address key areas such as understanding data quality and access constraints, ensuring ethical AI deployment, enhancing health system efficiency, and supporting informed decision-making at the point of care.

This funding will also support collaborative efforts with leading healthcare institutions and research organizations to validate and refine Symbiotic AI's technology. These partnerships are essential in ensuring that the solutions developed are robust, reliable, and widely applicable across diverse clinical settings.

"Receiving this funding is a testament to the dedication and expertise of our team," added Dr. Joon Lee, CTO and cofounder of Symbiotic AI. "We look forward to continuing our work with healthcare professionals and partners to drive innovation in heart healthcare and make a meaningful difference in Albertan's lives," said Arjun Puri, CEO of Symbiotic AI.

For more information about Symbiotic AI and its innovative solutions for heart healthcare, please visit www.symbioticai.ca or contact info@symbioticai.ca.

About Symbiotic AI

Symbiotic AI is a digital health company based in Calgary, Alberta, specializing in the development of clinical decision support software aimed at improving heart healthcare and patient outcomes. By leveraging the power of artificial intelligence and machine learning, Symbiotic AI delivers innovative solutions that empower healthcare providers with the tools they need to make informed and effective clinical decisions.

Media Contact:

Return to News Page